TRIANA Biomedicines
TRIANA Biomedicines is a biopharmaceutical company developing small molecule drugs that act as 'molecular glues' to treat previously undruggable diseases. The 64-person company has raised $281M in venture funding, including a Series B in December 2025.
The growth story
TRIANA Biomedicines grew from 7 to 64 employees between 2021 and 2026, raising $281M along the way, most recently a Series B in December 2025.
About
TRIANA Biomedicines creates small molecule drugs that bind proteins together to alter their function, targeting diseases that lack effective treatments. Its technology focuses on protein-protein interactions to address previously untreatable conditions.
The company has raised $281M from investors including Atlas Venture and Lightspeed Venture Partners. Its 64-person team includes 19 researchers, many recruited from pharmaceutical companies like Novartis and Pfizer.
Founders and leadership
TRIANA Biomedicines is led by a team with backgrounds in biopharma and venture capital. Research is the largest function, accounting for 19 of its 64 employees.
The TRIANA Biomedicines org chart
Patrick Trojer, PhD (Chief Executive Officer & President) leads 30 mapped leaders with 14 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 26 (+4% YoY), Business Development 14 (+56% YoY), Operations 4 (+100% YoY).
Talent flow
The company draws heavily from pharmaceutical firms, with 11 employees coming from Constellation Pharmaceuticals and 7 from Novartis. Harvard Medical School and Harvard University are also key talent sources.
Most common previous employers of TRIANA Biomedicines staff: Constellation Pharmaceuticals (11), Novartis (7), Harvard Medical School (6), Pfizer (3), Bristol Myers Squibb (3), Harvard University (3). Former TRIANA Biomedicines employees most often moved to MBX Biosciences (1), Hunterbrook Media (1), RA Capital Management (1), Judo Bio (1), Astellas Pharma (1), PsiThera (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at TRIANA Biomedicines: Drug Discovery (28), Biotechnology (27), Biochemistry (24), Life Sciences (24), Cell Culture (20), Molecular Biology (19), Oncology (17), Drug Development (17).
Where the team actually sits
TRIANA Biomedicines people are concentrated in Massachusetts, United States (37), Greater Boston (14), United States (4), New York City Metropolitan Area (1).
Search footprint
TRIANA Biomedicines attracts about 233 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 29 ranking keywords and lost 5 in the last period.
Frequently asked
TRIANA Biomedicines has 64 employees as of September 2026.
TRIANA Biomedicines has raised $281M in total, most recently a Series B round in December 2025.
TRIANA Biomedicines was founded in 2019 by Joshua Resnick.
Patrick Trojer, PhD (Chief Executive Officer & President) sits at the top of TRIANA Biomedicines's reporting structure, with 14 direct reports.
The most common previous employers of current TRIANA Biomedicines staff are Constellation Pharmaceuticals (11 people), Novartis (7 people), Harvard Medical School (6 people).
Former TRIANA Biomedicines employees most often move to MBX Biosciences (1), Hunterbrook Media (1), RA Capital Management (1).
TRIANA Biomedicines attracts about 233 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among TRIANA Biomedicines staff are Drug Discovery, Biotechnology, Biochemistry, Life Sciences, Cell Culture.
TRIANA Biomedicines staff are concentrated in Massachusetts, United States (37), Greater Boston (14), United States (4).
TRIANA Biomedicines has about 26 people in Research, up 4% over the past year, as of September 2026.
TRIANA Biomedicines has about 14 people in Business Development, up 56% over the past year, as of September 2026.
Computed from 57 current and 21 former TRIANA Biomedicines profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.